Merge CADstream with software versions earlier than 5.2.6. Distributed prior to March 2008 CADstream version 5.2.6 and newer are not affected by this recall. 의 리콜

Department of Health, Therapeutic Goods Administration에 따르면, 해당 리콜 는 Australia 에서 Emergo Asia Pacific Pty Ltd T/a Emergo Australia 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    RC-2016-RN-00868-1
  • 사례 위험등급
    Class II
  • 사례 시작날짜
    2016-06-30
  • 사례 국가
  • 사례 출처
    DHTGA
  • 사례 출처 URL
  • 비고 / 경고
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • 데이터 추가 비고
  • 원인
    This recall is due to a necessary modification to the cadstream difference threshold when used in conjunction with ge phased array uniformity enhancement (pure) for dynamic mri imaging & a lack of notification when cadstream detects the pure filter has been used.The pure feature is designed to minimise coil intensity variations through a calibration process & may affect the signal intensity values of images. for dynamic series, cadstream kinetic analysis relies on a consistent image acquisition protocol for each individual series in the dynamic series. if pure is applied to individual phases, it may change signal intensity values for the individual series, thus affecting the kinetics. this may result in a change in the amount of colour in the cadstream angiomap. scanning protocols and/or contrast agents that are inconsistent with background filter multiplier settings may result in a sub-optimal angiomap. this may result in a delay in diagnosis or treatment, or patient misdiagnosis.
  • 조치
    Merge has released software fix for this issue. The CADstream software fix will detect when a PURE filter is being used and display a notification to the end user. Emergo is providing users with a set of work around instructions to follow as an interim measure. This acion has been closed-out on 27/02/2017.

Device

  • 모델명 / 제조번호(시리얼번호)
    Merge CADstream with software versions earlier than 5.2.6. Distributed prior to March 2008 CADstream version 5.2.6 and newer are not affected by this recall.ARTG Number: 165390
  • Manufacturer

Manufacturer